article · Drug Design Development and Therapy
Based on the obtained results, the fluorinated analog <b>HR3</b> could serve as a novel therapeutic candidate for the amelioration of liver fibrosis that deserves further derivatizations and investigations.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.2147/dddt.s512058
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
